New York S08285 mandates warning labels on kratom products stating they are not FDA-approved and lists potential side effects; prohibits labeling.

New York S08285 amends the general business law to require manufacturers of kratom products sold within the state to include a warning label on each package stating that the product has not been approved by the FDA and lists potential side effects such as nausea, agitation, hallucinations, difficulty breathing, liver damage, and death. The bill also prohibits labeling these products as "all natural." Manufacturers violating these requirements face civil penalties of up to $500 for a first violation and up to $1,000 for subsequent violations.

New York S08285 mandates warning labels on kratom products stating they are not FDA-approved and lists potential side effects; prohibits labeling.

New York S08285 amends the general business law to require manufacturers of kratom products sold within the state to include a warning label on each package stating that the product has not been approved by the FDA and lists potential side effects such as nausea, agitation, hallucinations, difficulty breathing, liver damage, and death. The bill also prohibits labeling these products as "all natural." Manufacturers violating these requirements face civil penalties of up to $500 for a first violation and up to $1,000 for subsequent violations.